OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PPARα in the Epigenetic Driver Seat of NAFLD: New Therapeutic Opportunities for Epigenetic Drugs?
Claudia Theys, Dorien Lauwers, Claudina Pérez-Novo, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3041-3041
Open Access | Times Cited: 13
Claudia Theys, Dorien Lauwers, Claudina Pérez-Novo, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3041-3041
Open Access | Times Cited: 13
Showing 13 citing articles:
Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 64
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 64
HRD1-mediated ubiquitination of HDAC2 regulates PPARα-mediated autophagy and alleviates metabolic-associated fatty liver disease
Yina Wang, Yuanguo Chen, Xiao Xiao, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 7, pp. 119765-119765
Closed Access | Times Cited: 3
Yina Wang, Yuanguo Chen, Xiao Xiao, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 7, pp. 119765-119765
Closed Access | Times Cited: 3
PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments
Anna Skoczyńska, Monika Ołdakowska, Agnieszka Dobosz, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 786-786
Open Access | Times Cited: 3
Anna Skoczyńska, Monika Ołdakowska, Agnieszka Dobosz, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 786-786
Open Access | Times Cited: 3
Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
Ιωάννα Αγγελετοπούλου, Maria Kalafateli, Efthymios P. Tsounis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12864-12864
Open Access | Times Cited: 8
Ιωάννα Αγγελετοπούλου, Maria Kalafateli, Efthymios P. Tsounis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12864-12864
Open Access | Times Cited: 8
BNIP3 in hypoxia-induced mitophagy: Novel insights and promising target for non-alcoholic fatty liver disease
Meiyuan Tian, Jing Hou, Zhe Liu, et al.
The International Journal of Biochemistry & Cell Biology (2024) Vol. 168, pp. 106517-106517
Closed Access | Times Cited: 2
Meiyuan Tian, Jing Hou, Zhe Liu, et al.
The International Journal of Biochemistry & Cell Biology (2024) Vol. 168, pp. 106517-106517
Closed Access | Times Cited: 2
Dramatic Suppression of Lipogenesis and No Increase in Beta-Oxidation Gene Expression Are among the Key Effects of Bergamot Flavonoids in Fatty Liver Disease
Maddalena Parafati, Daniele La Russa, Antonella Lascala, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 766-766
Open Access | Times Cited: 2
Maddalena Parafati, Daniele La Russa, Antonella Lascala, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 766-766
Open Access | Times Cited: 2
m6A epitranscriptomic and epigenetic crosstalk in liver fibrosis: Special emphasis on DNA methylation and non-coding RNAs
Qi-Qi Dong, Yang Yang, Hui Tao, et al.
Cellular Signalling (2024) Vol. 122, pp. 111302-111302
Closed Access | Times Cited: 1
Qi-Qi Dong, Yang Yang, Hui Tao, et al.
Cellular Signalling (2024) Vol. 122, pp. 111302-111302
Closed Access | Times Cited: 1
Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD)
Claudia Theys, Tineke Vanderhaeghen, Evelien Van Dijck, et al.
Frontiers in Molecular Medicine (2024) Vol. 3
Open Access
Claudia Theys, Tineke Vanderhaeghen, Evelien Van Dijck, et al.
Frontiers in Molecular Medicine (2024) Vol. 3
Open Access
The new epigenetic driver role of PPARα and mitochondria in metabolic dysfunction associated liver disease (MASLD), paving the way towards new therapeutics and diagnostic biomarkers
Claudia Theys
(2024)
Open Access
Claudia Theys
(2024)
Open Access
The Interplay between Liver and Adipose Tissue in the Onset of Liver Diseases: Exploring the Role of Vitamin Deficiency
Ivan Tattoli, Aimee Rachel Mathew, Antonella Verrienti, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1631-1631
Open Access
Ivan Tattoli, Aimee Rachel Mathew, Antonella Verrienti, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1631-1631
Open Access
Exploring PPAR Gamma and PPAR Alpha’s Regulation Role in Metabolism via Epigenetics Mechanism
Małgorzata Małodobra-Mazur, Monika Ołdakowska, Tadeusz Dobosz
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1445-1445
Open Access
Małgorzata Małodobra-Mazur, Monika Ołdakowska, Tadeusz Dobosz
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1445-1445
Open Access
Post-translational histone modifications associated with the development of metabolic dysfunction-associated fatty liver disease. Part 2. Histone methylation
А.Е. Абатуров, Anna Nikulina
GASTROENTEROLOGY (2024) Vol. 58, Iss. 4, pp. 301-315
Open Access
А.Е. Абатуров, Anna Nikulina
GASTROENTEROLOGY (2024) Vol. 58, Iss. 4, pp. 301-315
Open Access
Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver Disorder
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, et al.
Current Drug Therapy (2023) Vol. 19, Iss. 1, pp. 20-48
Closed Access | Times Cited: 1
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, et al.
Current Drug Therapy (2023) Vol. 19, Iss. 1, pp. 20-48
Closed Access | Times Cited: 1
